Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
Alzheimer Disease
About this trial
This is an interventional treatment trial for Alzheimer Disease
Eligibility Criteria
Inclusion Criteria: Diagnosis of probable Alzheimer's disease using NINCDS-ADRDA criteria Mild to moderate degree of severity of dementia as assessed by the Mini-Mental Status Examination score of 16 to 26 (inclusive) Potential participant may be treated with conventional Alzheimer's disease therapy and must be on a stable dose for at least 6 months prior to the randomization and during the entire study period Potential participant must have a reliable caregiver and must be living in a community or in an assisted living facility Mother tongue is English, Spanish or French (oral and written fluency) Signed informed consent from potential participant or legal representative and identified caregiver Exclusion Criteria: Potential participant with any other cause of dementia. Potential participant with serious health problems other than Alzheimer's disease Use of an investigational drug within two months prior to randomization or during this study
Sites / Locations
- Neurological Physicians of Arizona, Inc.
- Pivotal Research Centers
- Pivotal Research Centers
- Northwest NeuroSpecialists
- Optimum Health Services
- Anderson Clinical Research
- Univ. of CT Health Center
- CNS Healthcare
- Mayo Clinic
- Renstar Medical Research
- Memory Disorder Center
- Neurological Center
- Vince and Associates Clinical Research
- Hartford Research Group
- Lexington Clinic
- LSUHSC Geriatric Psychiatry
- Brigham and Women's Hospital
- Synergy Medical
- University Medical Center, Dept. of Psychiatry Clinical Trials
- Radiant Research, Inc.
- Center For Emotional Fitness
- Ubhc/Umdnj667
- The Ohio State University
- The Clinical Trial Center
- Radiant Research
- Alzheimer's Research & Clinical Programs
- Harmony Research, Inc
- R/D Clinical Research, Inc.
- Grayline Clinical Drug Trial
- The Innovative Clinical Research Center
- Eastern Virginia Medical School - The Glennan Center For Geriatrics "Gerontology"
- National Clinical Research, Inc
- sanofi-aventis Australia & New Zealand administrative office
- Sanofi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office
- Sanfoi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office
- Sanofi-Aventis Administrative Office